Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Serotonin 5-HT5A receptor is a G protein-coupled receptor that binds serotonin and signals primarily through G_i/o proteins. It is expressed in multiple brain regions, including the raphe nuclei, cerebral cortex, hippocampus, and suprachiasmatic nucleus, implicating it in regulation of circadian rhythms, mood, cognitive function, and exploratory behavior. Despite its identification and cloning in the 1990s, the physiological roles of the 5-HT5A receptor have remained less defined compared to other serotonin receptors due to a shortage of selective ligands. Recent advances in structural biology (cryo-EM) and the discovery of selective antagonists have provided new tools for understanding its function and therapeutic potential. Emerging evidence points to a role for 5-HT5A in psychiatric disorders such as schizophrenia and depression
Agonists such as 5-CT activate the receptor, signaling via G_i/o proteins Antagonists (e.g., SB699551, ASP5736) block receptor activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-HT5A receptor (5-HT5A receptor).